Impact of trimester on morbidity of acute pyelonephritis in pregnancy

Am J Obstet Gynecol. 2009 Oct;201(4):406.e1-4. doi: 10.1016/j.ajog.2009.06.067. Epub 2009 Aug 18.

Abstract

Objective: We sought to compare maternal and neonatal morbidity as well as obstetric outcomes associated with pyelonephritis in pregnancy during the first compared to the second/third trimester.

Study design: A retrospective cohort analysis was performed of all pregnant women admitted to a single tertiary care hospital between January 2004 and June 2007 with pyelonephritis. The primary outcome was length of hospitalization. The study had 80% power to detect a 1-day difference in length of stay.

Results: In all, 219 cases of acute pyelonephritis were identified: 23 diagnosed in the first trimester and 196 in the second/third trimester. Women were hospitalized for a median of 4 days in both the first (range, 2-7) and second/third (range, 2-9; P = .6) trimesters. Neonatal and obstetric outcomes were not statistically significant.

Conclusion: Maternal morbidity and obstetric outcomes do not differ between first- and second-/third-trimester pyelonephritis. First-trimester pyelonephritis should be aggressively treated to prevent adverse outcomes.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Female
  • Humans
  • Length of Stay
  • Pregnancy
  • Pregnancy Outcome*
  • Pregnancy Trimester, First*
  • Pregnancy Trimester, Second*
  • Pyelonephritis
  • Retrospective Studies
  • Young Adult